Literature DB >> 25136095

Mannan induces ROS-regulated, IL-17A-dependent psoriasis arthritis-like disease in mice.

Ia Khmaladze1, Tiina Kelkka2, Simon Guerard1, Kajsa Wing1, Angela Pizzolla1, Amit Saxena1, Katarina Lundqvist3, Meirav Holmdahl3, Kutty Selva Nandakumar1, Rikard Holmdahl4.   

Abstract

Psoriasis (Ps) and psoriasis arthritis (PsA) are poorly understood common diseases, induced by unknown environmental factors, affecting skin and articular joints. A single i.p. exposure to mannan from Saccharomyces cerevisiae induced an acute inflammation in inbred mouse strains resembling human Ps and PsA-like disease, whereas multiple injections induced a relapsing disease. Exacerbation of disease severity was observed in mice deficient for generation of reactive oxygen species (ROS). Interestingly, restoration of ROS production, specifically in macrophages, ameliorated both skin and joint disease. Neutralization of IL-17A, mainly produced by γδ T cells, completely blocked disease symptoms. Furthermore, mice depleted of granulocytes were resistant to disease development. In contrast, certain acute inflammatory mediators (C5, Fcγ receptor III, mast cells, and histamine) and adaptive immune players (αβ T and B cells) were redundant in disease induction. Hence, we propose that mannan-induced activation of macrophages leads to TNF-α secretion and stimulation of local γδ T cells secreting IL-17A. The combined action of activated macrophages and IL-17A produced in situ drives neutrophil infiltration in the epidermis and dermis of the skin, leading to disease manifestations. Thus, our finding suggests a new mechanism triggered by exposure to exogenous microbial components, such as mannan, that can induce and exacerbate Ps and PsA.

Entities:  

Keywords:  Ncf1; animal model; autoimmune disease

Mesh:

Substances:

Year:  2014        PMID: 25136095      PMCID: PMC4156700          DOI: 10.1073/pnas.1405798111

Source DB:  PubMed          Journal:  Proc Natl Acad Sci U S A        ISSN: 0027-8424            Impact factor:   11.205


  59 in total

Review 1.  Recent insights into the immunopathogenesis of psoriasis provide new therapeutic opportunities.

Authors:  Brian J Nickoloff; Frank O Nestle
Journal:  J Clin Invest       Date:  2004-06       Impact factor: 14.808

2.  Anti-IL-17 mAbs herald new options in psoriasis.

Authors:  Ken Garber
Journal:  Nat Biotechnol       Date:  2012-06-07       Impact factor: 54.908

Review 3.  NOX2 complex-derived ROS as immune regulators.

Authors:  Outi Sareila; Tiina Kelkka; Angela Pizzolla; Malin Hultqvist; Rikard Holmdahl
Journal:  Antioxid Redox Signal       Date:  2011-04-11       Impact factor: 8.401

4.  Mechanism of pathogenesis of imiquimod-induced skin inflammation in the mouse: a role for interferon-alpha in dendritic cell activation by imiquimod.

Authors:  Azumi Ueyama; Mina Yamamoto; Kenichiro Tsujii; Yoko Furue; Chihiro Imura; Michitaka Shichijo; Kiyoshi Yasui
Journal:  J Dermatol       Date:  2014-01-03       Impact factor: 4.005

5.  The influence of macrophage depletion on ligament healing.

Authors:  Connie S Chamberlain; Ellen M Leiferman; Kayt E Frisch; Sijian Wang; Xipei Yang; Nico van Rooijen; Geoff S Baer; Stacey L Brickson; Ray Vanderby
Journal:  Connect Tissue Res       Date:  2010-11-30       Impact factor: 3.417

6.  The Koebner phenomenon.

Authors:  Lior Sagi; Henri Trau
Journal:  Clin Dermatol       Date:  2011 Mar-Apr       Impact factor: 3.541

Review 7.  Oxidative stress in the pathogenesis of psoriasis.

Authors:  Qiang Zhou; Ulrich Mrowietz; Martin Rostami-Yazdi
Journal:  Free Radic Biol Med       Date:  2009-07-03       Impact factor: 7.376

8.  A 9-centimorgan interval of chromosome 10 controls the T cell-dependent psoriasiform skin disease and arthritis in a murine psoriasis model.

Authors:  Honglin Wang; Daniel Kess; Anna-Karin B Lindqvist; Thorsten Peters; Anca Sindrilaru; Meinhard Wlaschek; Robert Blakytny; Rikard Holmdahl; Karin Scharffetter-Kochanek
Journal:  J Immunol       Date:  2008-04-15       Impact factor: 5.422

9.  Reactive oxygen species prevent imiquimod-induced psoriatic dermatitis through enhancing regulatory T cell function.

Authors:  Hyung-Ran Kim; Anbok Lee; Eun-Jeong Choi; Min-Pyo Hong; Jeong-Hae Kie; Woosung Lim; Hyeon Kook Lee; Byung-In Moon; Ju-Young Seoh
Journal:  PLoS One       Date:  2014-03-07       Impact factor: 3.240

10.  Delayed resolution of acute inflammation during zymosan-induced arthritis in leptin-deficient mice.

Authors:  Eiva Bernotiene; Gaby Palmer; Dominique Talabot-Ayer; Ildiko Szalay-Quinodoz; Michel L Aubert; Cem Gabay
Journal:  Arthritis Res Ther       Date:  2004-04-26       Impact factor: 5.156

View more
  43 in total

1.  LACC1 Regulates TNF and IL-17 in Mouse Models of Arthritis and Inflammation.

Authors:  Cara Skon-Hegg; Juan Zhang; Xiumin Wu; Meredith Sagolla; Naruhisa Ota; Arthur Wuster; Jennifer Tom; Emma Doran; Nandhini Ramamoorthi; Patrick Caplazi; John Monroe; Wyne P Lee; Timothy W Behrens
Journal:  J Immunol       Date:  2018-12-03       Impact factor: 5.422

Review 2.  Review: Enthesitis: New Insights Into Pathogenesis, Diagnostic Modalities, and Treatment.

Authors:  Amy S Kehl; Maripat Corr; Michael H Weisman
Journal:  Arthritis Rheumatol       Date:  2016-02       Impact factor: 10.995

3.  Rapid spread of mannan to the immune system, skin and joints within 6 hours after local exposure.

Authors:  C Hagert; R Siitonen; X-G Li; H Liljenbäck; A Roivainen; R Holmdahl
Journal:  Clin Exp Immunol       Date:  2019-02-27       Impact factor: 4.330

4.  Differential Role of B Cells and IL-17 Versus IFN-γ During Early and Late Rejection of Pig Islet Xenografts in Mice.

Authors:  Hee Kap Kang; Shusen Wang; Anil Dangi; Xiaomin Zhang; Amar Singh; Lei Zhang; James M Rosati; Wilma Suarez-Pinzon; Xuelian Deng; Xiaoyan Chen; Edward B Thorp; Bernhard J Hering; Stephen D Miller; Xunrong Luo
Journal:  Transplantation       Date:  2017-08       Impact factor: 4.939

5.  Augmented Th17 Differentiation Leads to Cutaneous and Synovio-Entheseal Inflammation in a Novel Model of Psoriatic Arthritis.

Authors:  Lu Yang; Melania H Fanok; Aranzazu Mediero-Munoz; Laura K Fogli; Carmen Corciulo; Shahla Abdollahi; Bruce N Cronstein; Jose U Scher; Sergei B Koralov
Journal:  Arthritis Rheumatol       Date:  2018-04-18       Impact factor: 10.995

6.  The Ubiquitin-Modifying Enzyme A20 Terminates C-Type Lectin Receptor Signals and Is a Suppressor of Host Defense against Systemic Fungal Infection.

Authors:  Jie Liang; Junyi J Zhang; Hsin-I Huang; Masashi Kanayama; Nourhan Youssef; Yingai J Jin; Estefany Y Reyes; Clare L Abram; Shigao Yang; Clifford A Lowell; Donghai Wang; Ling Shao; Mari L Shinohara; Jennifer Y Zhang; Gianna Elena Hammer
Journal:  Infect Immun       Date:  2020-08-19       Impact factor: 3.441

7.  Experimental lupus is aggravated in mouse strains with impaired induction of neutrophil extracellular traps.

Authors:  Deborah Kienhöfer; Jonas Hahn; Julia Stoof; Janka Zsófia Csepregi; Christiane Reinwald; Vilma Urbonaviciute; Caroline Johnsson; Christian Maueröder; Malgorzata J Podolska; Mona H Biermann; Moritz Leppkes; Thomas Harrer; Malin Hultqvist; Peter Olofsson; Luis E Munoz; Attila Mocsai; Martin Herrmann; Georg Schett; Rikard Holmdahl; Markus H Hoffmann
Journal:  JCI Insight       Date:  2017-05-18

8.  Metformin Promotes HaCaT Cell Apoptosis through Generation of Reactive Oxygen Species via Raf-1-ERK1/2-Nrf2 Inactivation.

Authors:  Xiaoyan Wang; Ronghua Li; Xintong Zhao; Xiaojing Yu; Qing Sun
Journal:  Inflammation       Date:  2018-06       Impact factor: 4.092

9.  (18)F-Labeling of Mannan for Inflammation Research with Positron Emission Tomography.

Authors:  Xiang-Guo Li; Cecilia Hagert; Riikka Siitonen; Helena Virtanen; Outi Sareila; Heidi Liljenbäck; Jouni Tuisku; Juhani Knuuti; Jörgen Bergman; Rikard Holmdahl; Anne Roivainen
Journal:  ACS Med Chem Lett       Date:  2016-05-16       Impact factor: 4.345

10.  Interleukin (IL)-9/IL-9R axis drives γδ T cells activation in psoriatic arthritis patients.

Authors:  G Guggino; F Ciccia; D Di Liberto; M Lo Pizzo; P Ruscitti; P Cipriani; A Ferrante; G Sireci; F Dieli; J J Fourniè; R Giacomelli; G Triolo
Journal:  Clin Exp Immunol       Date:  2016-10-21       Impact factor: 4.330

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.